Epidemiology of Depression in Heart Failure

Heart Failure Clinics

Volumn 7, Issue 1, 2011, Pages 1-10

  Gnanasekaran, Gowrishankar ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Depression; Epidemiology; Heart failure; Pathogenesis

Indexed keywords

CITALOPRAM; INTERLEUKIN 6; MIRTAZAPINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TUMOR NECROSIS FACTOR;

AGE DISTRIBUTION; AGING; CARDIOVASCULAR RISK; COGNITIVE THERAPY; CONGESTIVE HEART FAILURE; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFICACY; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; INCIDENCE; MORTALITY; PATHOPHYSIOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW;

ADAPTATION, PSYCHOLOGICAL; ANTIDEPRESSIVE AGENTS; COMORBIDITY; DEPRESSION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEART FAILURE; HUMANS; PREVALENCE; PROGNOSIS; PSYCHOMETRICS; QUALITY OF LIFE; RISK FACTORS; STRESS, PSYCHOLOGICAL; UNITED STATES;

EID: 78649427957     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2010.08.002     Document Type: Review

References (66)

1. Aimonino N., Tibaldi V., Barale S., et al. Depressive symptoms and quality of life in elderly patients with exacerbation of chronic obstructive pulmonary disease or cardiac heart failure: preliminary data of a randomized controlled trial. Arch Gerontol Geriatr 2007, 44(Suppl 1):7.
2. Freedland K.E., Rich M.W., Skala J.A., et al. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med 2003, 65:119.
3. Havranek E.P., Ware M.G., Lowes B.D. Prevalence of depression in congestive heart failure. Am J Cardiol 1999, 84:348.
4. Holzapfel N., Muller-Tasch T., Wild B., et al. Depression profile in patients with and without chronic heart failure. J Affect Disord 2008, 105:53.
5. Koenig H.G. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry 1998, 20:29.
6. Fulop G., Strain J.J., Stettin G. Congestive heart failure and depression in older adults: clinical course and health services use 6 months after hospitalization. Psychosomatics 2003, 44:367.
7. Sullivan M., Simon G., Spertus J., et al. Depression-related costs in heart failure care. Arch Intern Med 2002, 162:1860.
8. Unutzer J., Schoenbaum M., Katon W.J., et al. Healthcare costs associated with depression in medically Ill fee-for-service medicare participants. J Am Geriatr Soc 2009, 57:506.
9. Bekelman D.B., Dy S.M., Becker D.M., et al. Spiritual well-being and depression in patients with heart failure. J Gen Intern Med 2007, 22:470.
10. Carels R.A. The association between disease severity, functional status, depression and daily quality of life in congestive heart failure patients. Qual Life Res 2004, 13:63.
11. Egede L.E. Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. Gen Hosp Psychiatry 2007, 29:409.
12. Lopez A.D., Mathers C.D. Measuring the global burden of disease and epidemiological transitions: 2002-2030. Ann Trop Med Parasitol 2006, 100:481.
13. Albert N.M., Fonarow G.C., Abraham W.T., et al. Depression and clinical outcomes in heart failure: an OPTIMIZE-HF analysis. Am J Med 2009, 122:366.
14. Rutledge T., Reis V.A., Linke S.E., et al. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006, 48:1527.
15. Aujla N., Abrams K.R., Davies M.J., et al. The prevalence of depression in white-European and South-asian people with impaired glucose regulation and screen-detected type 2 diabetes mellitus. PLoS One 2009, 4:e7755.
16. Ell K., Katon W., Cabassa L.J., et al. Depression and diabetes among low-income Hispanics: design elements of a socioculturally adapted collaborative care model randomized controlled trial. Int J Psychiatry Med 2009, 39:113.
17. Fava G.A., Sonino N., Morphy M.A. Major depression associated with endocrine disease. Psychiatr Dev 1987, 5:321.
18. Abramson J., Berger A., Krumholz H.M., et al. Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch Intern Med 2001, 161:1725.
19. Krumholz H.M., Butler J., Miller J., et al. Prognostic importance of emotional support for elderly patients hospitalized with heart failure. Circulation 1998, 97:958.
20. Sherwood A., Blumenthal J.A., Trivedi R., et al. Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med 2007, 167:367.
21. Jiang W., Kuchibhatla M., Clary G.L., et al. Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J 2007, 154:102.
22. Gottlieb S.S., Khatta M., Friedmann E., et al. The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol 2004, 43:1542.
23. Williams S.A., Kasl S.V., Heiat A., et al. Depression and risk of heart failure among the elderly: a prospective community-based study. Psychosom Med 2002, 64:6.
24. Naqvi T.Z., Naqvi S.S., Merz C.N. Gender differences in the link between depression and cardiovascular disease. Psychosom Med 2005, 67(Suppl 1):S15.
25. Frasure-Smith N., Lesperance F., Habra M., et al. Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation 2009, 120:134.
26. Rohyans L.M., Pressler S.J. Depressive symptoms and heart failure: examining the sociodemographic variables. Clin Nurse Spec 2009, 23:138.
27. Cairns J.A., Connolly S.J., Roberts R., et al. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT): rationale and protocol. CAMIAT Investigators. Am J Cardiol 1993, 72:87F.
28. Delville C.L., McDougall G. A systematic review of depression in adults with heart failure: instruments and incidence. Issues Ment Health Nurs 2008, 29:1002.
29. Paradies G, Petrosillo G, Paradies V, et al. Oxidative stress, mitochondrial bioenergetics and cardiolipin in aging. Free Radic Biol Med 2010, 48(10):1286-1295.
30. Cicconetti P., Tafaro L., Tedeschi G., et al. Recenti Prog Med 2001, 92:731. [in Italian].
31. Guallar-Castillon P., Magarinos-Losada M.M., Montoto-Otero C., et al. Rev Esp Cardiol 2006, 59:770. [in Spanish].
32. Cassano P., Fava M. Depression and public health: an overview. J Psychosom Res 2002, 53:849.
33. Mallery L.H., MacDonald E.A., Hubley-Kozey C.L., et al. The feasibility of performing resistance exercise with acutely ill hospitalized older adults. BMC Geriatr 2003, 3:3.
34. Black S.A., Markides K.S. Depressive symptoms and mortality in older Mexican Americans. Ann Epidemiol 1999, 9:45.
35. Ahmed A., Ali M., Lefante C.M., et al. Geriatric heart failure, depression, and nursing home admission: an observational study using propensity score analysis. Am J Geriatr Psychiatry 2006, 14:867.
36. Chung M.L., Moser D.K., Lennie T.A., et al. The effects of depressive symptoms and anxiety on quality of life in patients with heart failure and their spouses: testing dyadic dynamics using Actor-Partner Interdependence Model. J Psychosom Res 2009, 67:29.
37. Friedman B., Lyness J.M., Delavan R.L., et al. Major depression and disability in older primary care patients with heart failure. J Geriatr Psychiatry Neurol 2008, 21:111.
38. Johansson P., Dahlstrom U., Brostrom A. Consequences and predictors of depression in patients with chronic heart failure: implications for nursing care and future research. Prog Cardiovasc Nurs 2006, 21:202.
39. Bagchi A.D., Esposito D., Kim M., et al. Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failure. Clin Ther 2007, 29:1771.
40. Hauptman P.J. Medication adherence in heart failure. Heart Fail Rev 2008, 13:99.
41. van der Wal M.H., Jaarsma T. Adherence in heart failure in the elderly: problem and possible solutions. Int J Cardiol 2008, 125:203.
42. Smith D.L. Compliance packaging: a patient education tool. Am Pharm 1989, NS29:42.
43. Casey E., Hughes J.W., Waechter D., et al. Depression predicts failure to complete phase-II cardiac rehabilitation. J Behav Med 2008, 31:421.
44. Grippo A.J., Johnson A.K. Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress 2009, 12:1.
45. Haenisch B., Linsel K., Bruss M., et al. Association of major depression with rare functional variants in norepinephrine transporter and serotonin1A receptor genes. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:1013.
46. Potter W.Z., Manji H.K. Catecholamines in depression: an update. Clin Chem 1994, 40:279.
47. Sahoo M., Subho C. Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates. Psychoneuroendocrinology 2007, 32:210. [author reply 211].
48. Benedict C.R., Johnstone D.E., Weiner D.H., et al. Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators. J Am Coll Cardiol 1994, 23:1410.
49. Deswal A., Petersen N.J., Feldman A.M., et al. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001, 103:2055.
50. Sliwa K., Skudicky D., Candy G., et al. Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy. Lancet 1998, 351:1091.
51. Smith R.S. The macrophage theory of depression. Med Hypotheses 1991, 35:298.
52. Zorrilla E.P., Luborsky L., McKay J.R., et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001, 15:199.
53. Catipovic-Veselica K., Galic A., Jelic K., et al. Relation between major and minor depression and heart rate, heart-rate variability, and clinical characteristics of patients with acute coronary syndrome. Psychol Rep 2007, 100:1245.
54. Markovitz J.H., Shuster J.L., Chitwood W.S., et al. Platelet activation in depression and effects of sertraline treatment: An open-label study. Am J Psychiatry 2000, 157:1006.
55. McCaffery J.M., Frasure-Smith N., Dube M.P., et al. Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosom Med 2006, 68:187.
56. Alexopoulos G.S., Streim J., Carpenter D., et al. Using antipsychotic agents in older patients. J Clin Psychiatry 2004, 65(Suppl 2):5.
57. Conn D.K., Goldman Z. Pattern of use of antidepressants in long-term care facilities for the elderly. J Geriatr Psychiatry Neurol 1992, 5:228.
58. Koenig H.G. Physician attitudes toward treatment of depression in older medical inpatients. Aging Ment Health 2007, 11:197.
59. O'Connor C.M., Jiang W., Kuchibhatla M., et al. Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med 2008, 168:2232.
60. Parissis J., Fountoulaki K., Paraskevaidis I., et al. Sertraline for the treatment of depression in coronary artery disease and heart failure. Expert Opin Pharmacother 2007, 8:1529.
61. Jaffe A.S., Krumholz H.M., Catellier D.J., et al. Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study. Am Heart J 2006, 152:126.
62. Frasure-Smith N. The montreal heart attack readjustment trial. J Cardiopulm Rehabil 1995, 15:103.
63. Frasure-Smith N., Lesperance F., Gravel G., et al. Long-term survival differences among low-anxious, high-anxious and repressive copers enrolled in the Montreal heart attack readjustment trial. Psychosom Med 2002, 64:571.
64. Shapiro P.A., Lesperance F., Frasure-Smith N., et al. An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial. Am Heart J 1999, 137:1100.
65. Shapiro P.A. Treatment of depression in patients with congestive heart failure. Heart Fail Rev 2009, 14:7.
66. de Jonge P., Honig A., van Melle J.P., et al. Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiatry 2007, 164:1371.